AURA
Price
$6.42
Change
-$0.25 (-3.75%)
Updated
Jun 13 closing price
Capitalization
398.07M
54 days until earnings call
SPRY
Price
$15.39
Change
+$0.99 (+6.88%)
Updated
Jun 13 closing price
Capitalization
1.51B
53 days until earnings call
Interact to see
Advertisement

AURA vs SPRY

Header iconAURA vs SPRY Comparison
Open Charts AURA vs SPRYBanner chart's image
Aura Biosciences
Price$6.42
Change-$0.25 (-3.75%)
Volume$152.63K
Capitalization398.07M
ARS Pharmaceuticals
Price$15.39
Change+$0.99 (+6.88%)
Volume$1.17M
Capitalization1.51B
AURA vs SPRY Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. SPRY commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and SPRY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (AURA: $6.42 vs. SPRY: $15.39)
Brand notoriety: AURA and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 73% vs. SPRY: 85%
Market capitalization -- AURA: $398.07M vs. SPRY: $1.51B
AURA [@Biotechnology] is valued at $398.07M. SPRY’s [@Biotechnology] market capitalization is $1.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 6 TA indicator(s) are bullish while SPRY’s TA Score has 8 bullish TA indicator(s).

  • AURA’s TA Score: 6 bullish, 2 bearish.
  • SPRY’s TA Score: 8 bullish, 1 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -1.23% price change this week, while SPRY (@Biotechnology) price change was +6.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

SPRY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.51B) has a higher market cap than AURA($398M). SPRY YTD gains are higher at: 45.877 vs. AURA (-21.898). SPRY has higher annual earnings (EBITDA): -27.07M vs. AURA (-101.63M). SPRY has more cash in the bank: 276M vs. AURA (128M). SPRY has less debt than AURA: SPRY (73K) vs AURA (18.4M). SPRY has higher revenues than AURA: SPRY (97.1M) vs AURA (0).
AURASPRYAURA / SPRY
Capitalization398M1.51B26%
EBITDA-101.63M-27.07M375%
Gain YTD-21.89845.877-48%
P/E RatioN/A152.50-
Revenue097.1M-
Total Cash128M276M46%
Total Debt18.4M73K25,205%
TECHNICAL ANALYSIS
Technical Analysis
AURASPRY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SWPPX92.29-1.04
-1.11%
Schwab® S&P 500 Index
LVOFX18.21-0.28
-1.51%
Lord Abbett Value Opportunities F
MIDKX23.35-0.37
-1.56%
Shelton S&P Midcap Index K
STSGX11.86-0.19
-1.58%
American Beacon Stephens Sm Cp Gr Inv
VSEIX51.44-0.98
-1.87%
JPMorgan Small Cap Equity I

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-3.75%
MGTX - AURA
53%
Loosely correlated
+0.61%
IDYA - AURA
50%
Loosely correlated
-0.45%
VRDN - AURA
49%
Loosely correlated
+1.34%
BEAM - AURA
49%
Loosely correlated
-2.18%
XNCR - AURA
47%
Loosely correlated
-2.55%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with ANAB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then ANAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+6.88%
ANAB - SPRY
37%
Loosely correlated
-0.38%
RCUS - SPRY
36%
Loosely correlated
-1.18%
AURA - SPRY
35%
Loosely correlated
-3.75%
APGE - SPRY
35%
Loosely correlated
+6.26%
KROS - SPRY
33%
Loosely correlated
-0.59%
More